ICH GCP EXAM BANK Multiple-Choice Questions and ANSWER
Key
SECTION 1: FUNDAMENTALS, PRINCIPLES, AND DEFINITIONS (Questions 1-50)
QUESTION 1
What is the primary purpose of ICH GCP?
A) To provide a legal framework for prosecuting clinical trial fraud.
B) To provide a unified international ethical and scientific quality standard for designing,
conducting, recording, and reporting trials .
C) To ensure clinical trials are completed within budget.
D) To standardize the marketing of pharmaceutical products.
ANSWER: B
Rationale: The ICH E6 guideline defines GCP as an international ethical and scientific
quality standard for trials involving human subjects. Its goal is to protect subject rights,
safety, and well-being, and to ensure data credibility .
QUESTION 2
Which of the following is the primary source of the ethical principles underpinning ICH
GCP?
A) The Nuremberg Code
B) The Belmont Report
C) The Declaration of Helsinki
D) The U.S. Federal Policy for the Protection of Human Subjects
ANSWER: C
Rationale: ICH GCP Principle 2.1 states that clinical trials should be conducted in
accordance with ethical principles that have their origin in the Declaration of Helsinki .
,QUESTION 3
According to ICH GCP Principle 2.3, which is the most important consideration in a clinical
trial?
A) The interests of science and society.
B) The interests of the sponsor.
C) The rights, safety, and well-being of trial subjects .
D) The reliability of the trial results.
ANSWER: C
Rationale: This principle is a cornerstone of GCP, emphasizing that the rights, safety, and
well-being of trial subjects are paramount and should prevail over the interests of science
and society .
QUESTION 4
A clinical trial should be initiated and continued only if the anticipated benefits justify:
A) The complexity of the trial protocol.
B) The cost of the trial.
C) The foreseeable risks and inconveniences .
D) The number of subjects required.
ANSWER: C
Rationale: ICH GCP Principle 2.2 mandates that before a trial is initiated, foreseeable risks
and inconveniences must be weighed against the anticipated benefit for the individual
subject and society. The trial should only continue if the benefits justify the risks .
QUESTION 5
What is required for a clinical trial to be scientifically sound?
A) A large budget.
B) A clear, detailed protocol .
C) A large number of subjects.
D) A well-known principal investigator.
ANSWER: B
,Rationale: ICH GCP Principle 2.5 states that clinical trials should be scientifically sound
and described in a clear, detailed protocol .
QUESTION 6
Who is responsible for the medical care and medical decisions made on behalf of trial
subjects?
A) The sponsor's medical monitor.
B) A qualified physician (or dentist, when appropriate) .
C) The Institutional Review Board.
D) The clinical research associate (CRA).
ANSWER: B
Rationale: According to ICH GCP Principle 2.7, medical care for and decisions on behalf of
subjects should always be the responsibility of a qualified physician or dentist .
QUESTION 7
Which principle states that each individual involved in conducting a trial should be
qualified by education, training, and experience?
A) Principle 2.6
B) Principle 2.7
C) Principle 2.8
D) Principle 2.9
ANSWER: C
Rationale: ICH GCP Principle 2.8 clearly requires all individuals involved in conducting a
trial to be qualified by education, training, and experience to perform their respective
tasks .
QUESTION 8
When must freely given informed consent be obtained from a trial subject?
A) At any time during the trial.
B) Prior to clinical trial participation .
C) After the first dose of the investigational product.
, D) Only when a subject experiences a serious adverse event.
ANSWER: B
Rationale: ICH GCP Principle 2.9 states that freely given informed consent should be
obtained from every subject prior to clinical trial participation .
QUESTION 9
How should clinical trial information be recorded, handled, and stored?
A) In a way that is cost-effective.
B) In a way that allows accurate reporting, interpretation, and verification .
C) In a way that is easily accessible to the public.
D) In a way that complies with the sponsor's marketing strategy.
ANSWER: B
Rationale: ICH GCP Principle 2.10 requires that all clinical trial information should be
recorded, handled, and stored in a way that allows for its accurate reporting, interpretation,
and verification .
QUESTION 10
What must be protected regarding records that could identify trial subjects?
A) Their availability to researchers.
B) The confidentiality of the records .
C) Their transfer to regulatory authorities.
D) Their inclusion in the clinical trial report.
ANSWER: B
Rationale: ICH GCP Principle 2.11 requires that the confidentiality of records that could
identify subjects should be protected, respecting privacy and confidentiality rules .
QUESTION 11
Investigational products should be manufactured in accordance with:
A) Good Clinical Practice (GCP).
B) Good Manufacturing Practice (GMP) .
C) Good Laboratory Practice (GLP).
Key
SECTION 1: FUNDAMENTALS, PRINCIPLES, AND DEFINITIONS (Questions 1-50)
QUESTION 1
What is the primary purpose of ICH GCP?
A) To provide a legal framework for prosecuting clinical trial fraud.
B) To provide a unified international ethical and scientific quality standard for designing,
conducting, recording, and reporting trials .
C) To ensure clinical trials are completed within budget.
D) To standardize the marketing of pharmaceutical products.
ANSWER: B
Rationale: The ICH E6 guideline defines GCP as an international ethical and scientific
quality standard for trials involving human subjects. Its goal is to protect subject rights,
safety, and well-being, and to ensure data credibility .
QUESTION 2
Which of the following is the primary source of the ethical principles underpinning ICH
GCP?
A) The Nuremberg Code
B) The Belmont Report
C) The Declaration of Helsinki
D) The U.S. Federal Policy for the Protection of Human Subjects
ANSWER: C
Rationale: ICH GCP Principle 2.1 states that clinical trials should be conducted in
accordance with ethical principles that have their origin in the Declaration of Helsinki .
,QUESTION 3
According to ICH GCP Principle 2.3, which is the most important consideration in a clinical
trial?
A) The interests of science and society.
B) The interests of the sponsor.
C) The rights, safety, and well-being of trial subjects .
D) The reliability of the trial results.
ANSWER: C
Rationale: This principle is a cornerstone of GCP, emphasizing that the rights, safety, and
well-being of trial subjects are paramount and should prevail over the interests of science
and society .
QUESTION 4
A clinical trial should be initiated and continued only if the anticipated benefits justify:
A) The complexity of the trial protocol.
B) The cost of the trial.
C) The foreseeable risks and inconveniences .
D) The number of subjects required.
ANSWER: C
Rationale: ICH GCP Principle 2.2 mandates that before a trial is initiated, foreseeable risks
and inconveniences must be weighed against the anticipated benefit for the individual
subject and society. The trial should only continue if the benefits justify the risks .
QUESTION 5
What is required for a clinical trial to be scientifically sound?
A) A large budget.
B) A clear, detailed protocol .
C) A large number of subjects.
D) A well-known principal investigator.
ANSWER: B
,Rationale: ICH GCP Principle 2.5 states that clinical trials should be scientifically sound
and described in a clear, detailed protocol .
QUESTION 6
Who is responsible for the medical care and medical decisions made on behalf of trial
subjects?
A) The sponsor's medical monitor.
B) A qualified physician (or dentist, when appropriate) .
C) The Institutional Review Board.
D) The clinical research associate (CRA).
ANSWER: B
Rationale: According to ICH GCP Principle 2.7, medical care for and decisions on behalf of
subjects should always be the responsibility of a qualified physician or dentist .
QUESTION 7
Which principle states that each individual involved in conducting a trial should be
qualified by education, training, and experience?
A) Principle 2.6
B) Principle 2.7
C) Principle 2.8
D) Principle 2.9
ANSWER: C
Rationale: ICH GCP Principle 2.8 clearly requires all individuals involved in conducting a
trial to be qualified by education, training, and experience to perform their respective
tasks .
QUESTION 8
When must freely given informed consent be obtained from a trial subject?
A) At any time during the trial.
B) Prior to clinical trial participation .
C) After the first dose of the investigational product.
, D) Only when a subject experiences a serious adverse event.
ANSWER: B
Rationale: ICH GCP Principle 2.9 states that freely given informed consent should be
obtained from every subject prior to clinical trial participation .
QUESTION 9
How should clinical trial information be recorded, handled, and stored?
A) In a way that is cost-effective.
B) In a way that allows accurate reporting, interpretation, and verification .
C) In a way that is easily accessible to the public.
D) In a way that complies with the sponsor's marketing strategy.
ANSWER: B
Rationale: ICH GCP Principle 2.10 requires that all clinical trial information should be
recorded, handled, and stored in a way that allows for its accurate reporting, interpretation,
and verification .
QUESTION 10
What must be protected regarding records that could identify trial subjects?
A) Their availability to researchers.
B) The confidentiality of the records .
C) Their transfer to regulatory authorities.
D) Their inclusion in the clinical trial report.
ANSWER: B
Rationale: ICH GCP Principle 2.11 requires that the confidentiality of records that could
identify subjects should be protected, respecting privacy and confidentiality rules .
QUESTION 11
Investigational products should be manufactured in accordance with:
A) Good Clinical Practice (GCP).
B) Good Manufacturing Practice (GMP) .
C) Good Laboratory Practice (GLP).
